Atomoxetine Clinical Trials

All Categories Medications / Interventions » Aa » Atomoxetine

Clinical Efficacy of Atomoxetine for Methamphetamine Dependence

Condition: Methamphetamine Dependence
Interventions: Drug: Atomoxetine; Drug: placebo
Sponsors: University of Arkansas; University of Arkansas; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012
Effects of Atomoxetine in Mild Cognitive Impairment

Condition: Mild Cognitive Impairment
Interventions: Drug: Atomoxetine; Drug: Placebo
Sponsors: Emory University; Emory University; National Institute on Aging (NIA)
Not yet recruiting - verified March 2012
Cognitive Effects of Atomoxetine in Humans: Genetic Moderators

Condition: Addiction
Interventions: Drug: Atomoxetine; Drug: Sugar Pill
Sponsors: Yale University; Yale University
Recruiting - verified December 2011
Cognitive Decline in Non-demented PD

Condition: Parkinson's Disease
Interventions: Drug: Strattera; Drug: Exelon; Other: Placebo
Sponsors: Oregon Health and Science University; Oregon Health and Science University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2012
Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Extended-release Guanfacine Hydrochloride; Drug: Atomoxetine Hydrochloride; Drug: Placebo Comparator
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified May 2012
Interventions for Children With Attention and Reading Disorders

Conditions: Attention Deficit Hyperactivity Disorder; Reading Difficulty or Disability
Interventions: Drug: Methylphenidate; Behavioral: Intensive reading instruction; Behavioral: Parent Training; Drug: Mixed Salt Amphetamine; Drug: Atomoxetine; Drug: Guanfacine
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012
Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: Lisdexamfetamine Dimesylate; Drug: Atomoxetine Hydrochloride
Sponsors: Shire Development LLC; Shire Development LLC
Recruiting - verified March 2012
Effects of Atomoxetine on Brain Activation During Attention and Reading Tasks in Patients With ADHD & Comorbid Dyslexia

Conditions: Attention Deficit Hyperactivity Disorder; Dyslexia
Interventions: Drug: Atomoxetine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified February 2012
Atomoxetine and Parent Management Training in Treating Children With Autism and Symptoms of Attention Deficit Disorder With Hyperactivity

Conditions: Autism; Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Atomoxetine; Behavioral: Parent management training (PMT); Drug: Placebo
Sponsors: University of Rochester; University of Rochester; National Institute of Mental Health (NIMH)
Recruiting - verified March 2009
Atomoxetine, Placebo and Parent Management Training in Autism

Conditions: Autism; Pervasive Developmental Disorder Not Otherwise Specified; Asperger's Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: atomoxetine; Drug: Placebo; Behavioral: Parent Management Training
Sponsors: University of Rochester; University of Rochester; University of Pittsburgh; Ohio State University
Recruiting - verified August 2011
Treatment of Orthostatic Hypotension

Conditions: Autonomic Nervous System Diseases; Orthostatic Hypotension
Interventions: Drug: droxidopa; Drug: placebo; Drug: alpha-methyldopa; Drug: carbidopa; Drug: metyrosine; Drug: levodopa; Drug: atomoxetine; Drug: metoclopramide
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified March 2012
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD

Conditions: Fetal Alcohol Syndrome; Attention Deficit Disorder With Hyperactivity (ADHD); Attention Deficit Disorder (ADD)
Interventions: Drug: Strattera; Drug: Placebo
Sponsors: University of Oklahoma; University of Oklahoma; Mark L. Wolraich, M.D.; Eli Lilly and Company
Recruiting - verified February 2012
Treatment of Orthostatic Intolerance

Conditions: Tachycardia; Chronic Orthostatic Intolerance
Interventions: Drug: Acetazolamide; Drug: Atomoxetine; Other: Baseline (No Drug); Drug: Clonidine; Drug: Entacapone; Drug: Entacapone & Propranolol; Drug: Atomoxetine & Propranolol; Drug: Indomethacin; Drug: Mecamylamine; Drug: Isosorbide Dinitrate; Dietary Supplement: Melatonin; Drug: Midodrine; Drug: Modafinil; Drug: Octreotide; Radiation: Placebo; Drug: Propranolol; Drug: Modafinil & Propranolol; Drug: Sertraline; Procedure: IV Saline; Other: Drinking Water; Device: Breathing Device; Drug: memantine; Device: Abdominal binder
Sponsors: Vanderbilt University; Satish R. Raj; National Institutes of Health (NIH)
Recruiting - verified February 2012
Treatment of Orthostatic Hypotension in Autonomic Failure

Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012